258 related articles for article (PubMed ID: 19674909)
21. Synthesis and cytotoxic activity of 17-carboxylic acid modified 23-hydroxy betulinic acid ester derivatives.
Bi Y; Xu J; Wu X; Ye W; Yuan S; Zhang L
Bioorg Med Chem Lett; 2007 Mar; 17(5):1475-8. PubMed ID: 17275295
[TBL] [Abstract][Full Text] [Related]
22. Simple structural modifications confer cytotoxicity to allobetulin.
Heller L; Obernauer A; Csuk R
Bioorg Med Chem; 2015 Jul; 23(13):3002-12. PubMed ID: 26007303
[TBL] [Abstract][Full Text] [Related]
23. A 3D QSAR study of betulinic acid derivatives as anti-tumor agents using topomer CoMFA: model building studies and experimental verification.
Ding W; Sun M; Luo S; Xu T; Cao Y; Yan X; Wang Y
Molecules; 2013 Aug; 18(9):10228-41. PubMed ID: 23973995
[TBL] [Abstract][Full Text] [Related]
24. New ursolic and betulinic derivatives as potential cytotoxic agents.
Baglin I; Poumaroux A; Nour M; Tan K; Mitaine-Offer AC; Lacaille-Dubois MA; Chauffert B; Cavé C
J Enzyme Inhib Med Chem; 2003 Apr; 18(2):111-7. PubMed ID: 12943194
[TBL] [Abstract][Full Text] [Related]
25. Anticancer activity of 3-O-acylated betulinic acid derivatives obtained by enzymatic synthesis.
Ahmad FB; Ghaffari Moghaddam M; Basri M; Abdul Rahman MB
Biosci Biotechnol Biochem; 2010; 74(5):1025-9. PubMed ID: 20460723
[TBL] [Abstract][Full Text] [Related]
26. Antileishmanial activity of semisynthetic lupane triterpenoids betulin and betulinic acid derivatives: synergistic effects with miltefosine.
Sousa MC; Varandas R; Santos RC; Santos-Rosa M; Alves V; Salvador JA
PLoS One; 2014; 9(3):e89939. PubMed ID: 24643019
[TBL] [Abstract][Full Text] [Related]
27. Combination of amino acid/dipeptide with ligustrazine-betulinic acid as antitumor agents.
Xu B; Yan WQ; Xu X; Wu GR; Zhang CZ; Han YT; Chu FH; Zhao R; Wang PL; Lei HM
Eur J Med Chem; 2017 Apr; 130():26-38. PubMed ID: 28237794
[TBL] [Abstract][Full Text] [Related]
28. Carbamate derivatives of betulinic acid and betulin with selective cytotoxic activity.
Kommera H; Kaluderović GN; Dittrich S; Kalbitz J; Dräger B; Mueller T; Paschke R
Bioorg Med Chem Lett; 2010 Jun; 20(11):3409-12. PubMed ID: 20451375
[TBL] [Abstract][Full Text] [Related]
29. Design and Synthesis of NO-releasing Betulinic Acid Derivatives as Potential Anticancer Agents.
Liu J; Zhu Z; Tang J; Lin Q; Chen L; Sun J
Anticancer Agents Med Chem; 2017; 17(2):241-249. PubMed ID: 27671295
[TBL] [Abstract][Full Text] [Related]
30. Cytotoxic heterocyclic triterpenoids derived from betulin and betulinic acid.
Urban M; Vlk M; Dzubak P; Hajduch M; Sarek J
Bioorg Med Chem; 2012 Jun; 20(11):3666-74. PubMed ID: 22551630
[TBL] [Abstract][Full Text] [Related]
31. Synthesis of betulinic acid derivatives with activity against human melanoma.
Kim DS; Pezzuto JM; Pisha E
Bioorg Med Chem Lett; 1998 Jul; 8(13):1707-12. PubMed ID: 9873420
[TBL] [Abstract][Full Text] [Related]
32. Betulinic Acid-Nitrogen Heterocyclic Derivatives: Design, Synthesis, and Antitumor Evaluation
Yang Y; Xie T; Tian X; Han N; Liu X; Chen H; Qi J; Gao F; Li W; Wu Q; Huo S; Gu Y; Dai Z; Wang P; Lei H
Molecules; 2020 Feb; 25(4):. PubMed ID: 32093264
[TBL] [Abstract][Full Text] [Related]
33. Synthesis of heterocycle-modified betulinic acid derivatives as antitumor agents.
Cui HW; He Y; Wang J; Gao W; Liu T; Qin M; Wang X; Gao C; Wang Y; Liu MY; Yi Z; Qiu WW
Eur J Med Chem; 2015 May; 95():240-8. PubMed ID: 25817774
[TBL] [Abstract][Full Text] [Related]
34. Mitochondria-Targeted Lupane Triterpenoid Derivatives and Their Selective Apoptosis-Inducing Anticancer Mechanisms.
Ye Y; Zhang T; Yuan H; Li D; Lou H; Fan P
J Med Chem; 2017 Jul; 60(14):6353-6363. PubMed ID: 28671831
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and cytotoxic activity of heterocyclic ring-substituted betulinic acid derivatives.
Kumar V; Rani N; Aggarwal P; Sanna VK; Singh AT; Jaggi M; Joshi N; Sharma PK; Irchhaiya R; Burman AC
Bioorg Med Chem Lett; 2008 Sep; 18(18):5058-62. PubMed ID: 18752941
[TBL] [Abstract][Full Text] [Related]
36. Recent Developments in the Functionalization of Betulinic Acid and Its Natural Analogues: A Route to New Bioactive Compounds.
Sousa JLC; Freire CSR; Silvestre AJD; Silva AMS
Molecules; 2019 Jan; 24(2):. PubMed ID: 30669472
[TBL] [Abstract][Full Text] [Related]
37. Design, synthesis, and anti-tumor activity of novel betulinic acid derivatives.
Liu JH; Tang J; Zhu ZF; Chen L
J Asian Nat Prod Res; 2014 Jan; 16(1):34-42. PubMed ID: 24350921
[TBL] [Abstract][Full Text] [Related]
38. A convergent synthesis of novel alkyne-azide cycloaddition congeners of betulinic acid as potent cytotoxic agent.
Dangroo NA; Singh J; Rath SK; Gupta N; Qayum A; Singh S; Sangwan PL
Steroids; 2017 Jul; 123():1-12. PubMed ID: 28435038
[TBL] [Abstract][Full Text] [Related]
39. Triphenylphosphonium Analogues of Betulin and Betulinic Acid with Biological Activity: A Comprehensive Review.
Grymel M; Zawojak M; Adamek J
J Nat Prod; 2019 Jun; 82(6):1719-1730. PubMed ID: 31141361
[TBL] [Abstract][Full Text] [Related]
40. Lupane triterpenoids--betulin and betulinic acid derivatives induce apoptosis in tumor cells.
Kommera H; Kaluđerović GN; Kalbitz J; Paschke R
Invest New Drugs; 2011 Apr; 29(2):266-72. PubMed ID: 19957199
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
